Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL046341-03S2
Application #
877353
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-02-01
Project End
1996-01-31
Budget Start
1994-03-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Temple University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Omburo, G A; Jacobitz, S; Torphy, T J et al. (1998) Critical role of conserved histidine pairs HNXXH and HDXXH in recombinant human phosphodiesterase 4A. Cell Signal 10:491-7
Sheth, S B; Chaganti, K; Bastepe, M et al. (1997) Cyclic AMP phosphodiesterases in human lymphocytes. Br J Haematol 99:784-9
Omburo, G A; Torphy, T J; Scott, G et al. (1997) Inactivation of recombinant monocyte cAMP-specific phosphodiesterase by cAMP analog, 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphate. Blood 89:1019-26
Sheth, S B; Brennan, K J; Biradavolu, R et al. (1997) Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells. Thromb Haemost 77:155-62
Cheung, P P; Xu, H; McLaughlin, M M et al. (1996) Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis. Blood 88:1321-9
Ghazaleh, F A; Omburo, G A; Colman, R W (1996) Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase. Biochem J 317 ( Pt 2):495-501
Sheth, S B; Colman, R W (1995) Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design. Semin Hematol 32:110-9
Omburo, G A; Brickus, T; Ghazaleh, F A et al. (1995) Divalent metal cation requirement and possible classification of cGMP-inhibited phosphodiesterase as a metallohydrolase. Arch Biochem Biophys 323:1-5